# Xin Heng Rui

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xin-heng-rui

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $14M
- Latest round: Series A (Jul 17, 2023)
- Investors on record: 3

## About

Founded in 2021 and based in Shanghai, China, Xin Heng Rui is a medical technology company that focuses on the research and development of cardiac assisting medical devices. In July 2023, the company raised approximately CNY 100 million in series A funding led by new investor IDG Capital. Other new investors Everest and Huaige Capital also participated in the round.

The company's core product is the Omniheart percutaneous ventricular assist device. The Omniheart percutaneous ventricular assist device features a tiny implanted motor and an intelligent safety monitoring system. The firm also provides interventional heart pumps for short- and medium-term support, surgical extracorporeal circulation pumps, long-term implantable artificial hearts, and other products.

## Funding rounds

- Series A, Jul 17, 2023, $14M — IDG Capital, Everest VC, Huaige Capital

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Everest VC (https://capitalatlas.ai/funds/everest-vc) — Series A
- Huaige Capital (https://capitalatlas.ai/funds/huaige-capital) — Series A